Basf India Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 19, 2026

Key Highlights

The Latest Trading Price of BASF India Ltd is ₹ 3309 as of 19 Mar 15:30 . The P/E Ratio of BASF India Ltd changed from 25.6 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 83.2 on March 2024 to 81.2 on March 2023 . This represents a CAGR of -0.49% over 5 years The Market Cap of BASF India Ltd changed from ₹ 14443 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 2525 crore on March 2024 to ₹ 3694 crore on March 2023 . This represents a CAGR of 7.91% over 5 years The revenue of BASF India Ltd for the Dec '25 is ₹ 3874 crore as compare to the Sep '25 revenue of ₹ 3927 crore. This represent the decline of -1.34% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of BASF India Ltd for the Dec '25 is ₹ 181.81 crore as compare to the Sep '25 ebitda of ₹ 186.24 crore. This represent the decline of -2.38% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of BASF India Ltd changed from ₹ 220.57 crore to ₹ 106.67 crore over 7 quarters. This represents a CAGR of -33.97% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of BASF India Ltd changed from 7.83 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About BASF India Ltd

BASF India Limited, the flagship company of the BASF Group in India was incorporated as 'R A Cole Private Limited' on May 13, 1943 and the name was changed to Indoplast Limited in January, 1963.
The Company got their name changed to BASF India Limited in February, 1999. BASF India Limited is a leading transnational company in the Indian chemical industry.
The company's portfolio is organized into 6 segments: Agricultural Solutions, Materials, Industrial solutions, Surface Technologies, Nutrition & Care and Chemicals.
The Agricultural Solutions business includes products for crop protection like insecticides, herbicides, fungicides and plant growth regulators.
The Performance Products segment includes the Performance Chemicals, Dispersions & Pigments, Care Chemicals, Nutrition & Health products and Paper Chemicals businesses.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of BASF India Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, BASF India Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of BASF India Ltd is 14,326 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,700 Cr

What are the key factors driving the stock performance of BASF India Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of BASF India Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for BASF India Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 19, 2026, the BASF India Ltd stock price is INR ₹3309.75. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1154.4.

How do dividend payouts of BASF India Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of BASF India Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.